Proceedings of the American Thoracic Society · 2009 · 25 citations · 48 references
MedicineDevelopmental BiologyPediatricsDevelopmental PediatricsPediatric PulmonologyPulmonologyLung DevelopmentPediatric Airway DisordersRespiratory DiseaseRespiratory System DevelopmentLung DiseasesNeonatal WheezingPediatric Research ReviewPediatric Wheeze PhenotypesPersonalized Medicine ImplementationPostnatal Lung Development
The Division of Lung Diseases of the National Heart, Lung, and Blood Institute (NHLBI) recently held a workshop to identify gaps in our understanding and treatment of childhood lung diseases and to define strategies to enhance translational research in this field. Leading experts with diverse experience in both laboratory and patient-oriented research reviewed selected areas of pediatric lung diseases, including perinatal programming and epigenetic influences; mechanisms of lung injury, repair, and regeneration; pulmonary vascular disease; sleep and control of breathing; and the application of novel translational methods to enhance personalized medicine. This report summarizes the proceedings of this workshop and provides recommendations for emphasis on targeted areas for future investigation. The priority areas identified for research in pediatric pulmonary diseases included: (1) epigenetic and environmental influences on lung development that program pediatric lung diseases; (2) injury, regeneration, and repair in the developing lung; (3) pulmonary vascular disease in children; (4) development and adaptation of ventilatory responses to postnatal life; (5) nonatopic wheezing: aberrant large airway development or injury?; (6) strategies to improve assessment, diagnosis, and treatment of pediatric respiratory diseases; and (7) predictive and personalized medicine for children.
48
Asthma and Wheezing in the First Six Years of Life
Fernando D. Martínez, Anne L. Wright, Lynn M. Taussig et al. · New England Journal of Medicine · 1995 · 3.8K citations · Full text
Medicine, Child Health, Pediatrics +13
National surveillance for asthma--United States, 1980-2004.
Jeanne E. Moorman, Rose A. Rudd, Carol Johnson et al. · PubMed · 2007 · 1.4K citations
Public Health, Chronic Disease Control, Public Health Practice +17
Role of deficient type III interferon-λ production in asthma exacerbations
Marco Contoli, Simon Message, Vasile Laza‐Stanca et al. · Nature Medicine · 2006 · 1K citations